TRPC3 and ovarian carcinoma: Mechanistically, PLAA inhibited METTL3 expression through the ubiquitin-mediated degradation and destabilized TRPC3 expression via METTL3-mediated m6A modification, which consequently suppressed intracellular calcium concentration and ovarian cancer metastasis.